3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Basal Cell Nevus Syndrome
3
Carcinoma, Basal Cell
2
Skin Neoplasms
1
Interventions
pembrolizumab
15
Nivolumab
10
Ipilimumab
7
cemiplimab
6
dabrafenib
4
binimetinib
4
Dacarbazine
4
trametinib
3
encorafenib
3
Drug Therapy
3
Allovectin-7
3
zanolimumab
2
talabostat
2
lifileucel
2
aldesleukin
2
Vemurafenib
2
Tablets
2
Semaxinib
2
Intravital Microscopy
2
Interleukin-2
2
Fluorouracil
2
vitespin
1
veliparib
1
varlilumab
1
tozuleristide
1
tin etiopurpurin
1
tilsotolimod
1
spartalizumab
1
sotigalimab
1
sonidegib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Skin Neoplasms
×
gusacitinib
×
Clear all
NCT02550678
2018-06-06
ASN-002-001
Ascend Biopharmaceuticals Ltd
Phase 1/2
Completed
16 enrolled